## Abstract ## Background. We examined the psychological distress in patients with head and neck cancer and investigated how preoperative selfโesteem influenced psychological distress during treatment. ## Methods. Fiftyโeight patients who were scheduled for surgery for head and neck cancer parti
Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial
โ Scribed by Kathryn E. Lazure; William M. Lydiatt; David Denman; William J. Burke
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 129 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background.
To determine if depression portends a worse prognosis in patients with head and neck cancer, we conducted a retrospective chart analysis of subjects who participated in a randomized placeboโcontrolled trial of citalopram for the prevention of depression during head and neck cancer treatment. Thirtyโfive patients were randomized, 34 with 1 or more evaluations form the basis of this report.
Methods.
We used the Hamilton Depression Rating Scale (HDRS), with a minimum followโup of 24 months if no evidence of disease, or until recurrence or death from disease.
Results.
Fourteen of 34 subjects were depressed at any time during the 16 week RCT (HAMD >15). Seven of the 14 subjects in the depressed group were dead from disease or had recurrence, compared to 4 of 20 who never developed depression (p = .03). Stage of disease was equivalent in the 2 groups.
Conclusion.
This study suggests that depression in patients with head and neck cancer reduces survival. ยฉ 2009 Wiley Periodicals, Inc. Head Neck, 2009
๐ SIMILAR VOLUMES
Patients with head and neck cancer have to cope not only with a life threatening diagnosis, but also with an altered facial appearance and the loss or impairment of important functions as a result of treatment. As a consequence they are prone to psychosocial problems. Social support might influence
## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Fortyโtwo patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv
## Abstract There has been concern that the efficacy of radiation therapy may be reduced when patients smoke or take antioxidant vitamins during treatment. Cancer prevention trials with beta carotene supplements documented adverse effects only among smokers. We conducted a randomized trial with alp